Neola Medical AB (publ) (STO:NEOLA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.6450
-0.0100 (-1.53%)
Jul 24, 2026, 12:24 PM CET

Neola Medical AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9.018.3310.399.839.7511.1
Revenue Growth
-1.02%-19.86%5.73%0.85%-12.21%279.78%
Gross Profit
8.828.059.028.068.329.77
Operating Income
-11.99-11.09-10.8-9.62-10.39-6.65
Net Income
-11.95-11.02-10.06-9.01-10.35-6.65
Earnings Per Share
-0.16-0.14-0.14-0.17-0.40-0.47
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
9.9616.1219.5621.5840.0922.94
Net Cash Growth
-69.52%-17.56%-9.38%-46.17%74.76%37.80%
Cash & Investments
9.9616.1219.5621.5840.0922.94
Net Cash Per Share
0.130.210.280.391.541.64

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12.67-9.71-9.18-6.54-8.5-6.93
Capital Expenditures
--0.06-0.150-0.1-0.17
Free Cash Flow
-12.67-9.78-9.32-6.54-8.6-7.1
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
97.83%96.71%86.83%82.04%85.41%88.02%
Operating Margin
-133.00%-133.20%-103.91%-97.88%-106.57%-59.93%
Pretax Margin
-132.61%-132.35%-96.84%-91.67%-106.23%-59.93%
Profit Margin
-132.61%-132.35%-96.84%-91.67%-106.23%-59.93%
FCF Margin
-140.59%-117.39%-89.69%-66.56%-88.24%-63.98%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.579.9213.6413.927.714.89